HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diarrhea D003967 32 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Tumor Virus Infections D014412 8 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Sarcoma D012509 3 associated lipids
Bacterial Infections D001424 21 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Mouth Diseases D009059 5 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Carcinoma, Squamous Cell D002294 14 associated lipids
Skin Neoplasms D012878 12 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Precancerous Conditions D011230 48 associated lipids
Stomach Neoplasms D013274 24 associated lipids
Carcinoma D002277 18 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Femoral Neck Fractures D005265 3 associated lipids
Granuloma D006099 5 associated lipids
Rodent Diseases D012376 4 associated lipids
Coronary Disease D003327 70 associated lipids
Osteosarcoma D012516 50 associated lipids
Carcinoma, Small Cell D018288 21 associated lipids
Brain Neoplasms D001932 15 associated lipids
Hypothyroidism D007037 32 associated lipids
Embolism D004617 3 associated lipids
Heart Diseases D006331 8 associated lipids
Occupational Diseases D009784 42 associated lipids
Brain Diseases D001927 27 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Bone Diseases D001847 4 associated lipids
Calcinosis D002114 5 associated lipids
Myocardial Infarction D009203 21 associated lipids
Prostatic Hyperplasia D011470 20 associated lipids
Alzheimer Disease D000544 76 associated lipids
Teratoma D013724 4 associated lipids
Hyperplasia D006965 34 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Peripheral Nervous System Diseases D010523 33 associated lipids
Dental Pulp Necrosis D003790 6 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Sinusitis D012852 9 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Neoplasms, Multiple Primary D009378 8 associated lipids
Glomerulonephritis D005921 35 associated lipids
Brain Infarction D020520 17 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Creutzfeldt-Jakob Syndrome D007562 7 associated lipids
Brain Ischemia D002545 89 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Metaplasia D008679 7 associated lipids
Echinococcosis D004443 2 associated lipids
Meningioma D008579 11 associated lipids
Rhinitis, Allergic, Perennial D012221 6 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Palatal Neoplasms D010157 2 associated lipids
Swine Diseases D013553 16 associated lipids
Listeriosis D008088 12 associated lipids
Poultry Diseases D011201 21 associated lipids
Candidiasis D002177 3 associated lipids
Heart Arrest D006323 13 associated lipids
HIV Infections D015658 20 associated lipids
Rabies D011818 4 associated lipids
Cerebellar Neoplasms D002528 9 associated lipids
Medulloblastoma D008527 22 associated lipids
Neurilemmoma D009442 10 associated lipids
Spinal Cord Neoplasms D013120 3 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Atherosclerosis D050197 85 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Tinea D014005 5 associated lipids
Endotoxemia D019446 27 associated lipids
Blister D001768 16 associated lipids
Keratosis D007642 9 associated lipids
Tularemia D014406 3 associated lipids
Mycoses D009181 18 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Tinea Versicolor D014010 5 associated lipids
Sigmoid Neoplasms D012811 5 associated lipids
Helicobacter Infections D016481 21 associated lipids
Wounds, Penetrating D014950 10 associated lipids
Mucositis D052016 7 associated lipids
Carcinoma, Mucoepidermoid D018277 3 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Beau-Faller M et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. 2009 Br. J. Cancer pmid:19293811
Berney DM et al. Ki-67 and outcome in clinically localised prostate cancer: analysis of conservatively treated prostate cancer patients from the Trans-Atlantic Prostate Group study. 2009 Br. J. Cancer pmid:19293807
Rogers HA et al. An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET). 2009 Br. J. Cancer pmid:19293793
Barshack I et al. Spectral morphometric characterization of breast carcinoma cells. 1999 Br. J. Cancer pmid:10188915
Kawanishi H et al. Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation. 2007 Br. J. Cancer pmid:17579624
Modok S et al. Transport kinetics of four- and six-coordinate platinum compounds in the multicell layer tumour model. 2007 Br. J. Cancer pmid:17579620
Nakagawa S et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. 2004 Br. J. Cancer pmid:14710229
Yoshikawa R et al. Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy. 2008 Br. J. Cancer pmid:18475300
Hamma-Kourbali Y et al. Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice. 2003 Br. J. Cancer pmid:12838326
Yao H et al. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer. 2004 Br. J. Cancer pmid:15494722
Pardo FS et al. Mutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineage. 2004 Br. J. Cancer pmid:15494720
Tang Z et al. Dual MET-EGFR combinatorial inhibition against T790M-EGFR-mediated erlotinib-resistant lung cancer. 2008 Br. J. Cancer pmid:19238632
Abd El-Rehim DM et al. Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma. 2004 Br. J. Cancer pmid:15480434
Hussain SA et al. Proapoptotic genes BAX and CD40L are predictors of survival in transitional cell carcinoma of the bladder. 2003 Br. J. Cancer pmid:12592374
Spizzo G et al. Correlation of COX-2 and Ep-CAM overexpression in human invasive breast cancer and its impact on survival. 2003 Br. J. Cancer pmid:12592372
Pelosi G et al. Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer. 2003 Br. J. Cancer pmid:12592367
Nishikawa M et al. Accumulation of mitochondrial DNA mutation with colorectal carcinogenesis in ulcerative colitis. 2005 Br. J. Cancer pmid:15956973
Pattje WJ et al. The phosphatase and tensin homologue deleted on chromosome 10 mediates radiosensitivity in head and neck cancer. 2010 Br. J. Cancer pmid:20502457
Onda M et al. Decreased expression of haemoglobin beta (HBB) gene in anaplastic thyroid cancer and recovery of its expression inhibits cell growth. 2005 Br. J. Cancer pmid:15956966
Kim MS et al. Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias. 2008 Br. J. Cancer pmid:18392055
O'Callaghan G et al. Prostaglandin E2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. 2008 Br. J. Cancer pmid:18648368
Moniaux N et al. Early diagnosis of pancreatic cancer: neutrophil gelatinase-associated lipocalin as a marker of pancreatic intraepithelial neoplasia. 2008 Br. J. Cancer pmid:18392050
Ni X et al. Characterisation of human kallikrein 6/protease M expression in ovarian cancer. 2004 Br. J. Cancer pmid:15305183
Elkahwaji JE et al. Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate. 2009 Br. J. Cancer pmid:19844236
Yamato I et al. Clinical importance of B7-H3 expression in human pancreatic cancer. 2009 Br. J. Cancer pmid:19844235
Shrout J et al. beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. 2008 Br. J. Cancer pmid:18506145
Andersen CL et al. Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer. 2009 Br. J. Cancer pmid:19156145
Kronqvist P et al. Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. 2002 Br. J. Cancer pmid:12439717
Sersa G et al. Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. 2002 Br. J. Cancer pmid:12434299
Fan LZ and Cherian MG Potential role of p53 on metallothionein induction in human epithelial breast cancer cells. 2002 Br. J. Cancer pmid:12434295
de Micco C et al. Utility of malignancy markers in fine-needle aspiration cytology of thyroid nodules: comparison of Hector Battifora mesothelial antigen-1, thyroid peroxidase and dipeptidyl aminopeptidase IV. 2008 Br. J. Cancer pmid:18212751
Nehls O et al. Studies on p53, BAX and Bcl-2 protein expression and microsatellite instability in stage III (UICC) colon cancer treated by adjuvant chemotherapy: major prognostic impact of proapoptotic BAX. 2007 Br. J. Cancer pmid:17426704
Thews O et al. Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia. 2004 Br. J. Cancer pmid:15305198
Gaballah K et al. The antiangiogenic agent ZD4190 prevents tumour outgrowth in a model of minimal residual carcinoma in deep tissues. 2009 Br. J. Cancer pmid:19623179
Elie C et al. Lack of relationship between EGFR-1 immunohistochemical expression and prognosis in a multicentre clinical trial of 93 patients with advanced primary ovarian epithelial cancer (GINECO group). 2004 Br. J. Cancer pmid:15226774
Ogawa E et al. Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients. 2004 Br. J. Cancer pmid:15226767
Collet JF et al. Galectin-3 immunodetection in follicular thyroid neoplasms: a prospective study on fine-needle aspiration samples. 2005 Br. J. Cancer pmid:16251880
Chen YL et al. Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behaviour. 2002 Br. J. Cancer pmid:12177809
Baeten CI et al. Flow cytometric quantification of tumour endothelial cells; an objective alternative for microvessel density assessment. 2002 Br. J. Cancer pmid:12177806
Zou L et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. 2007 Br. J. Cancer pmid:17940506
Hettiaratchi A et al. The collagenase-1 (MMP-1) gene promoter polymorphism - 1607/2G is associated with favourable prognosis in patients with colorectal cancer. 2007 Br. J. Cancer pmid:17311017
Janssen CS et al. The T1799A point mutation is present in posterior uveal melanoma. 2008 Br. J. Cancer pmid:18985043
van Beers EH et al. A multiplex PCR predictor for aCGH success of FFPE samples. 2006 Br. J. Cancer pmid:16333309
Ding SL et al. Abnormality of the DNA double-strand-break checkpoint/repair genes, ATM, BRCA1 and TP53, in breast cancer is related to tumour grade. 2004 Br. J. Cancer pmid:15138484
Patmore HS et al. Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation? 2004 Br. J. Cancer pmid:15138481
Sivridis E et al. Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis. 2002 Br. J. Cancer pmid:11986782
Hildenbrand R and Arens N Protein and mRNA expression of uPAR and PAI-1 in myoepithelial cells of early breast cancer lesions and normal breast tissue. 2004 Br. J. Cancer pmid:15226768
Bignotti E et al. Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 2011 Br. J. Cancer pmid:21468050
Garcia S et al. c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays. 2007 Br. J. Cancer pmid:17242702
Hagemann T et al. Molecular profiling of cervical cancer progression. 2007 Br. J. Cancer pmid:17242701
Kommoss S et al. Independent prognostic significance of cell cycle regulator proteins p16(INK4a) and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group. 2007 Br. J. Cancer pmid:17242700
Ueno Y et al. Selective inhibition of TNF-alpha-induced activation of mitogen-activated protein kinases and metastatic activities by gefitinib. 2005 Br. J. Cancer pmid:15841081
Kato T et al. A quantitative analysis of lymphatic vessels in human breast cancer, based on LYVE-1 immunoreactivity. 2005 Br. J. Cancer pmid:16251871
Preuss SF et al. Nuclear survivin expression is associated with HPV-independent carcinogenesis and is an indicator of poor prognosis in oropharyngeal cancer. 2008 Br. J. Cancer pmid:18212752
Dai DL et al. Reduced Apaf-1 expression in human cutaneous melanomas. 2004 Br. J. Cancer pmid:15305193
Wang JH et al. Detection of human parvovirus B19 in papillary thyroid carcinoma. 2008 Br. J. Cancer pmid:18212749
Grützmann R et al. ADAM9 expression in pancreatic cancer is associated with tumour type and is a prognostic factor in ductal adenocarcinoma. 2004 Br. J. Cancer pmid:14997207
Vicent S et al. ERK1/2 is activated in non-small-cell lung cancer and associated with advanced tumours. 2004 Br. J. Cancer pmid:14997206
Fontanini G et al. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. 2002 Br. J. Cancer pmid:11870537
Awwad HK et al. Accelerated hyperfractionation (AHF) compared to conventional fractionation (CF) in the postoperative radiotherapy of locally advanced head and neck cancer: influence of proliferation. 2002 Br. J. Cancer pmid:11870530
Rofstad EK and Halsør EF Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8. 2002 Br. J. Cancer pmid:11870523
Cheng Q et al. Identification of molecular markers for the early detection of human squamous cell carcinoma of the uterine cervix. 2002 Br. J. Cancer pmid:11870519
Brooks LA et al. E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. 2002 Br. J. Cancer pmid:11870517
Horiguchi J et al. Prognostic significance of dihydropyrimidine dehydrogenase expression in breast cancer. 2002 Br. J. Cancer pmid:11870510
Koumakpayi IH et al. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer. 2010 Br. J. Cancer pmid:20216540
Bluff JE et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. 2009 Br. J. Cancer pmid:19623180
Watermann DO et al. Specific induction of pp125 focal adhesion kinase in human breast cancer. 2005 Br. J. Cancer pmid:16136050
Barros-Silva JD et al. Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. 2009 Br. J. Cancer pmid:19156142
Ito Y et al. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. 2004 Br. J. Cancer pmid:14735186
Mizukami Y et al. Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. 2008 Br. J. Cancer pmid:18841157
Van der Auwera I et al. Aberrant methylation of the Adenomatous Polyposis Coli (APC) gene promoter is associated with the inflammatory breast cancer phenotype. 2008 Br. J. Cancer pmid:18841156
Deans DA et al. Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. 2006 Br. J. Cancer pmid:17088911
Stecker K et al. Impact of the coxsackievirus and adenovirus receptor on the adenoma-carcinoma sequence of colon cancer. 2011 Br. J. Cancer pmid:21468049
Kawaraya M et al. Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer. 2003 Br. J. Cancer pmid:14612897
Dangles V et al. Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns. 2002 Br. J. Cancer pmid:11953886
Rand V et al. Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma. 2008 Br. J. Cancer pmid:18781180
Debergh I et al. The low-molecular-weight heparin, nadroparin, inhibits tumour angiogenesis in a rodent dorsal skinfold chamber model. 2010 Br. J. Cancer pmid:20125158
Liao YH et al. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma. 2011 Br. J. Cancer pmid:21343931
Vlahovic G et al. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. 2006 Br. J. Cancer pmid:17003785
Kikuchi M et al. High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction. 2009 Br. J. Cancer pmid:19491899
Jenkinson SR et al. S100A4 regulates cell motility and invasion in an in vitro model for breast cancer metastasis. 2004 Br. J. Cancer pmid:14710237
Ugurel S et al. Lack of clinical efficacy of imatinib in metastatic melanoma. 2005 Br. J. Cancer pmid:15846297
Brown NS et al. Cooperative stimulation of vascular endothelial growth factor expression by hypoxia and reactive oxygen species: the effect of targeting vascular endothelial growth factor and oxidative stress in an orthotopic xenograft model of bladder carcinoma. 2005 Br. J. Cancer pmid:15841086
Langbein S et al. Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. 2006 Br. J. Cancer pmid:16465194
Kurokawa T et al. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. 2003 Br. J. Cancer pmid:12966423
Hudelist G et al. Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. 2003 Br. J. Cancer pmid:12966413
Surowiak P et al. Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers. 2006 Br. J. Cancer pmid:16892043
Baker MJ et al. FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. 2008 Br. J. Cancer pmid:18985044
Hartana CA et al. Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours. 2016 Br. J. Cancer pmid:27599044
Nonomura N et al. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. 2007 Br. J. Cancer pmid:17848955
Seenath MM et al. Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer. 2008 Br. J. Cancer pmid:18648372
Lawrie LC et al. Liver fatty acid binding protein expression in colorectal neoplasia. 2004 Br. J. Cancer pmid:15138477
Landers KA et al. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. 2008 Br. J. Cancer pmid:18648369
Fondevila C et al. p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. 2004 Br. J. Cancer pmid:14710231
Hashida H et al. Clinical significance of transmembrane 4 superfamily in colon cancer. 2003 Br. J. Cancer pmid:12838318
Yamamoto T et al. No major tumorigenic role for beta-catenin in serrated as opposed to conventional colorectal adenomas. 2003 Br. J. Cancer pmid:12838317
Shyu RY et al. RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma. 2003 Br. J. Cancer pmid:12838316
Southern SA et al. Induction of tetrasomy by human papillomavirus type 16 E7 protein is independent of pRb binding and disruption of differentiation. 2004 Br. J. Cancer pmid:15138476
Górka B et al. NrCAM, a neuronal system cell-adhesion molecule, is induced in papillary thyroid carcinomas. 2007 Br. J. Cancer pmid:17667921
Minas V et al. Intratumoral CRH modulates immuno-escape of ovarian cancer cells through FasL regulation. 2007 Br. J. Cancer pmid:17667919